Table 1.
General characteristics of included studies
Ref. | Year | Country | Study design | No. of patients | Cytology diagnostic category | Reference standard | LBC type |
Chun et al[9] | 2019 | South Korea | Prospective | 338 | I/B/A/S/M | Combined | SurePath |
Zhou et al[7] | 2019 | China | Retrospective | 514 | I/A/S/M/B/N | Combined | SurePath |
Yeon et al[10] | 2018 | South Korea | Prospective | 48 | I/B/A/S/M | Combined | CellprepPlus |
Lee et al[12] | 2011 | South Korea | Prospective | 58 | I/B/S/M | Combined | ThinPrep |
LeBlanc et al[13] | 2010 | America | Prospective | 50 | I/B/A/S/M | Histology | ThinPrep |
Qin et al[3] | 2014 | China | Prospective | 72 | B/M | Combined | ThinPrep |
Hashimoto et al[11] | 2017 | Japan | Prospective | 265 | M/S/B | Combined | SurePath |
Itonaga et al[8] | 2019 | Japan | Retrospective | 311 | B/M | Combined | ThinPrep |
I: Inadequate; B: Benign; A: Atypical; S: Suspicious; M: Malignant; N: Neoplastic; LBC: Liquid-based cytology.